Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
One of J&J's investments stands head-and-shoulders above the rest.
Overview
You probably know Johnson & Johnson (NYSE: JNJ) mainly for its prescription medications. Some may be familiar with the company's medical devices. But J&J has another role that many people may not know about: It's a healthcare investor.
Johnson & Johnson's latest 13F filing revealed a portfolio of 15 biotech stocks and medtech stocks. The regulatory document provides a window into where one of the world's largest healthcare companies by market cap is placing its bets. And one of those bets stands above the rest, in my opinion.
Image source: Johnson & Johnson.
Details
Source
Originally published at www.fool.com.
Related Articles
- Historic $7.5 million L.A. home restored by ‘Rocky Horror’ actor Tim Curry finds a buyer just hours after his death
- Both Hedge Funds and Mutual Funds Are Buying These Fantastic Fintech Stocks, and That's a Great Signal for Investors to Buy
- Here’s what Prince Harry and Meghan Markle’s California mansion could really be worth, and how much it costs to keep it up
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.